Vanguard Investments Australia
LGND icon

Vanguard Investments Australia’s Ligand Pharmaceuticals LGND Stock Holding History

Vanguard Investments Australia’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
5,073
+271
+6% +$63.9K ﹤0.01% 1025
2026
Q1 		$959K Buy
+4,802
New +$950K ﹤0.01% 1225

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Investments Australia's LGND Position: Q2 2026 in Review

Vanguard Investments Australia increased its Ligand Pharmaceuticals (LGND) stake by 5.6% in Q2 2026, buying an estimated $63.9K and bringing the position to 5,073 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Vanguard Investments Australia first reported a position in LGND in Q1 2026 and has held it in 2 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Vanguard Investments Australia held 5,073 shares of Ligand Pharmaceuticals worth $1.6M as of Q2 2026.
  • Vanguard Investments Australia bought 271 Ligand Pharmaceuticals shares in Q2 2026, an estimated $63.9K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1025 holding.
  • Vanguard Investments Australia first reported a position in Ligand Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.